The role of stromal cancer-associated fibroblasts in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer generally refractory to conventional treatments. Cancer-associated fibroblasts (CAFs) are cellular components of the desmoplastic stroma characteristic to the tumor that contributes to this treatment resistance. Various markers for...

Full description

Bibliographic Details
Main Authors: Dagny von Ahrens, Tushar D. Bhagat, Deepak Nagrath, Anirban Maitra, Amit Verma
Format: Article
Language:English
Published: BMC 2017-03-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13045-017-0448-5
_version_ 1818590565930893312
author Dagny von Ahrens
Tushar D. Bhagat
Deepak Nagrath
Anirban Maitra
Amit Verma
author_facet Dagny von Ahrens
Tushar D. Bhagat
Deepak Nagrath
Anirban Maitra
Amit Verma
author_sort Dagny von Ahrens
collection DOAJ
description Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer generally refractory to conventional treatments. Cancer-associated fibroblasts (CAFs) are cellular components of the desmoplastic stroma characteristic to the tumor that contributes to this treatment resistance. Various markers for CAFs have been explored including palladin and CD146 that have prognostic and functional roles in the pathobiology of PDAC. Mechanisms of CAF-tumor cell interaction have been described including exosomal transfer and paracrine signaling mediated by cytokines such as GM-CSF and IL-6. The role of downstream signaling pathways including JAK/STAT, mTOR, sonic hedge hog (SHH), and NFkB have also been shown to play an important function in PDAC-CAF cross talk. The role of autophagy and other metabolic effects on each cell type within the tumor have also been proposed to play roles in facilitating CAF secretory function and enhancing tumor growth in a low-glucose microenvironment. Targeting the stroma has gained interest with multiple preclinical and clinical trials targeting SHH, JAK2, and methods of either exploiting the secretory capability of CAFs to enhance drug delivery or inhibiting it to prevent its influence on cancer cell chemoresistance. This review summarizes the most recent progress made in understanding stromal formation; its contribution to tumor proliferation, invasion, and metastasis; its role in chemoresistance; and potential therapeutic strategies on the horizon.
first_indexed 2024-12-16T09:58:34Z
format Article
id doaj.art-f1c7b67a887b4b5e87dee103f1dae157
institution Directory Open Access Journal
issn 1756-8722
language English
last_indexed 2024-12-16T09:58:34Z
publishDate 2017-03-01
publisher BMC
record_format Article
series Journal of Hematology & Oncology
spelling doaj.art-f1c7b67a887b4b5e87dee103f1dae1572022-12-21T22:35:51ZengBMCJournal of Hematology & Oncology1756-87222017-03-011011810.1186/s13045-017-0448-5The role of stromal cancer-associated fibroblasts in pancreatic cancerDagny von Ahrens0Tushar D. Bhagat1Deepak Nagrath2Anirban Maitra3Amit Verma4Albert Einstein College of MedicineAlbert Einstein College of MedicineDepartment of Biomedical Engineering, University of MichiganThe University of Texas MD Anderson Cancer CenterAlbert Einstein College of MedicineAbstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer generally refractory to conventional treatments. Cancer-associated fibroblasts (CAFs) are cellular components of the desmoplastic stroma characteristic to the tumor that contributes to this treatment resistance. Various markers for CAFs have been explored including palladin and CD146 that have prognostic and functional roles in the pathobiology of PDAC. Mechanisms of CAF-tumor cell interaction have been described including exosomal transfer and paracrine signaling mediated by cytokines such as GM-CSF and IL-6. The role of downstream signaling pathways including JAK/STAT, mTOR, sonic hedge hog (SHH), and NFkB have also been shown to play an important function in PDAC-CAF cross talk. The role of autophagy and other metabolic effects on each cell type within the tumor have also been proposed to play roles in facilitating CAF secretory function and enhancing tumor growth in a low-glucose microenvironment. Targeting the stroma has gained interest with multiple preclinical and clinical trials targeting SHH, JAK2, and methods of either exploiting the secretory capability of CAFs to enhance drug delivery or inhibiting it to prevent its influence on cancer cell chemoresistance. This review summarizes the most recent progress made in understanding stromal formation; its contribution to tumor proliferation, invasion, and metastasis; its role in chemoresistance; and potential therapeutic strategies on the horizon.http://link.springer.com/article/10.1186/s13045-017-0448-5PancreasAdenocarcinomaStromaTumor microenvironmentCancer-associated fibroblast
spellingShingle Dagny von Ahrens
Tushar D. Bhagat
Deepak Nagrath
Anirban Maitra
Amit Verma
The role of stromal cancer-associated fibroblasts in pancreatic cancer
Journal of Hematology & Oncology
Pancreas
Adenocarcinoma
Stroma
Tumor microenvironment
Cancer-associated fibroblast
title The role of stromal cancer-associated fibroblasts in pancreatic cancer
title_full The role of stromal cancer-associated fibroblasts in pancreatic cancer
title_fullStr The role of stromal cancer-associated fibroblasts in pancreatic cancer
title_full_unstemmed The role of stromal cancer-associated fibroblasts in pancreatic cancer
title_short The role of stromal cancer-associated fibroblasts in pancreatic cancer
title_sort role of stromal cancer associated fibroblasts in pancreatic cancer
topic Pancreas
Adenocarcinoma
Stroma
Tumor microenvironment
Cancer-associated fibroblast
url http://link.springer.com/article/10.1186/s13045-017-0448-5
work_keys_str_mv AT dagnyvonahrens theroleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT tushardbhagat theroleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT deepaknagrath theroleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT anirbanmaitra theroleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT amitverma theroleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT dagnyvonahrens roleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT tushardbhagat roleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT deepaknagrath roleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT anirbanmaitra roleofstromalcancerassociatedfibroblastsinpancreaticcancer
AT amitverma roleofstromalcancerassociatedfibroblastsinpancreaticcancer